Regeneron Pharmaceuticals, Inc. (BVMF:REGN34)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	420,738	436,198	474,006	453,222	407,367	367,893
Market Cap Growth	-4.88%	-7.98%	4.59%	11.26%	10.73%	38.93%
Enterprise Value	340,297	347,938	377,624	390,193	352,972	319,306
Last Close Price	67.75	70.91	72.57	67.85	62.76	59.14
PE Ratio	16.96	17.58	17.37	23.63	17.76	8.18
PS Ratio	5.33	5.52	5.40	7.12	6.33	4.11
PB Ratio	2.44	2.53	2.61	3.60	3.40	3.52
P/TBV Ratio	2.55	2.64	2.72	3.75	3.54	3.52
P/FCF Ratio	18.72	19.41	20.91	24.10	17.42	10.11
P/OCF Ratio	15.34	15.91	17.34	20.33	15.37	9.32
EV/Sales Ratio	4.55	4.40	4.30	6.13	5.49	3.57
EV/EBITDA Ratio	15.23	14.88	13.19	17.28	12.51	6.18
EV/EBIT Ratio	17.61	17.06	14.73	19.00	13.37	6.37
EV/FCF Ratio	15.14	15.48	16.66	20.75	15.09	8.78
Debt / Equity Ratio	0.11	0.11	0.12	0.11	0.12	0.14
Debt / EBITDA Ratio	0.81	0.81	0.75	0.60	0.52	0.29
Debt / FCF Ratio	0.85	0.85	0.95	0.72	0.63	0.41
Asset Turnover	0.37	0.37	0.40	0.42	0.45	0.76
Inventory Turnover	2.53	2.53	2.51	2.51	2.37	2.74
Quick Ratio	3.28	3.28	3.86	4.82	4.16	2.98
Current Ratio	4.13	4.13	4.73	5.69	5.06	3.56
Return on Equity (ROE)	14.87%	14.87%	15.95%	16.26%	20.94%	54.21%
Return on Assets (ROA)	5.91%	5.91%	7.31%	8.49%	11.42%	26.39%
Return on Invested Capital (ROIC)	12.42%	12.77%	18.34%	22.38%	26.65%	60.13%
Return on Capital Employed (ROCE)	10.20%	10.20%	12.30%	14.30%	19.20%	41.80%
Earnings Yield	5.90%	5.69%	5.76%	4.23%	5.63%	12.23%
FCF Yield	5.34%	5.15%	4.78%	4.15%	5.74%	9.89%
Dividend Yield	0.32%	27.34%	-	-	-	-
Payout Ratio	0.10%	8.22%	-	-	-	-
Buyback Yield / Dilution	5.65%	5.65%	-1.23%	-0.18%	-1.16%	2.52%
Total Shareholder Return	5.97%	32.99%	-1.23%	-0.18%	-1.16%	2.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.